A three-country comparison of psychotropic medication prevalence in youth
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The study aims to compare cross-national prevalence of psychotropic medication use in youth. METHODS: A population-based analysis of psychotropic medication use based on administrative claims data for the year 2000 was undertaken for insured enrollees from 3 countries in relation to age group (0-4, 5-9, 10-14, and 15-19), gender, drug subclass pattern and concomitant use. The data include insured youth aged 0-19 in the year 2000 from the Netherlands (n = 110,944), Germany (n = 356,520) and the United States (n = 127,157). RESULTS: The annual prevalence of any psychotropic medication in youth was significantly greater in the US (6.7%) than in the Netherlands (2.9%) and in Germany (2.0%). Antidepressant and stimulant prevalence were 3 or more times greater in the US than in the Netherlands and Germany, while antipsychotic prevalence was 1.5-2.2 times greater. The atypical antipsychotic subclass represented only 5% of antipsychotic use in Germany, but 48% in the Netherlands and 66% in the US. The less commonly used drugs e.g. alpha agonists, lithium and antiparkinsonian agents generally followed the ranking of US>Dutch>German youth with very rare (less than 0.05%) use in Dutch and German youth. Though rarely used, anxiolytics were twice as common in Dutch as in US and German youth. Prescription hypnotics were half as common as anxiolytics in Dutch and US youth and were very uncommon in German youth. Concomitant drug use applied to 19.2% of US youth which was more than double the Dutch use and three times that of German youth. CONCLUSION: Prominent differences in psychotropic medication treatment patterns exist between youth in the US and Western Europe and within Western Europe. Differences in policies regarding direct to consumer drug advertising, government regulatory restrictions, reimbursement policies, diagnostic classification systems, and cultural beliefs regarding the role of medication for emotional and behavioral treatment are likely to account for these differences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The rates of increase of pediatric psychotropic drug prescription in the US are alarming (30,34).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [34]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The duration of stimulant drug treatment has also greatly increased (34)(35)(36).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Social Transformation of American Medicine
Leavitt, J. W., & Starr, P. (1984) · The American Historical Review · doi:10.2307/1862729 · Cited by 3,247
Basic and Clinical Biostatistics,
(2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00360-0 · Cited by 1,809
McPherson, K., Wennberg, J. E., Hovind, O. B., & Clifford, P. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211183072104 · Cited by 822
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1032 · Cited by 724
The Social Transformation of American Medicine
MUELLER, C. B. (1983) · Archives of Surgery · doi:10.1001/archsurg.1983.01390120071024 · Cited by 614
Attention-deficit hyperactivity disorder and hyperkinetic disorder
Swanson, J., Sergeant, J., Taylor, E., Sonuga-Barke, E., Jensen, P., & Cantwell, D. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11450-7 · Cited by 601
Attention-deficit hyperactivity disorder and hyperkinetic disorder
Swanson, J. M., Sergeant, J. A., Taylor, E., Sonuga-Barke, E. J. S., Jensen, P. S., & Cantwell, D. P. (2001) · Attention Deficit Hyperactivity Disorders · doi:10.4324/9781315054315-2 · Cited by 572
Psychotropic Practice Patterns for Youth: A 10-Year Perspective
Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., Boles, M., Lynch, F., & Riddle, M. A. (2003) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.157.1.17 · Cited by 526
Self-citationBasic and Clinical Biostatistics
Rosenbaum, S. E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460050106033 · Cited by 415
Pharmacoepidemiology and Drug Safety
Mucklow, J. C. (1992) · Postgraduate Medical Journal · doi:10.1136/pgmj.68.804.846-b · Cited by 296
Research works printed but not linked: 2
- Chiang CL Standard error of the age-adjusted death rate US Dept HEW: Vital Statistics Special Reports 1961 47 271 285
- Zito JM Safer DJ Fegert JM Tobi H Janhsen K Glaeske G Menis M Ryu J Neuroleptic prevalence for youths: a multi-national comparison Poster presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry Toronto 2005
Cited by
(2013) · PubMed · Cited by 770
Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009) · Health Affairs · doi:10.1377/hlthaff.28.5.w770 · Cited by 268
Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review
Jobski, K., Höfer, J., Hoffmann, F., & Bachmann, C. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12644 · Cited by 263
Treatment of Young People With Antipsychotic Medications in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0500 · Cited by 249
Vitiello, B., Correll, C., van Zwieten-Boot, B., Zuddas, A., Parellada, M., & Arango, C. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.04.008 · Cited by 222
Psychotropic medicine consumption in 65 countries and regions, 2008-19: A longitudinal study
Brauer, R., Alfageh, B., Blais, J. E., Chan, E. W., Chui, C. S. L., Hayes, J. F., Man, K. K. C., Lau, W. C. Y., Yan, V. K. C., Beykloo, M. Y., et al. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00292-3 · Cited by 203
Fischer, B., Keates, A., Bühringer, G., Reimer, J., & Rehm, J. (2014) · Addiction · doi:10.1111/add.12224 · Cited by 147
Antipsychotic Medication Prescribing Trends in Children and Adolescents
Harrison, J. N., Cluxton-Keller, F., & Gross, D. (2012) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2011.10.009 · Cited by 175
Trends in ADHD medication use in children and adolescents in five western countries, 2005–2012
Bachmann, C., Wijlaars, L. P. M. M., Kalverdijk, L. J., Burcu, M., Glaeske, G., Schuiling‐Veninga, C. C. M., Hoffmann, F., Aagaard, L., & ZITO, J. M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.03.002 · Cited by 171
Self-citationZetterqvist, J., Asherson, P., Halldner, L., Långström, N., & Larsson, H. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12004 · Cited by 152
Metabolic Screening in Children Receiving Antipsychotic Drug Treatment
Morrato, E. H., Nicol, G. E., Maahs, D., Druss, B. G., Hartung, D. M., Valuck, R. J., Campagna, E., & Newcomer, J. W. (2010) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2010.48 · Cited by 148
Brault, M.-C., & Lacourse, É. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700206 · Cited by 111
Huerta, C., Abbing‐Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., Miret, M., Schneider, C., Gil, M., Souverein, P. C., et al. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3825 · Cited by 130
Focusing on the negative: Cultural differences in expressions of sympathy.
Koopmann‐Holm, B., & Tsai, J. L. (2014) · Journal of Personality and Social Psychology · doi:10.1037/a0037684 · Cited by 142
Recent international trends in psychotropic medication prescriptions for children and adolescents
Steinhausen, H. (2014) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-014-0631-y · Cited by 139
Challenges and Opportunities in Measuring the Quality of Mental Health Care
Kilbourne, A. M., Keyser, D., & Pincus, H. A. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500903 · Cited by 109
Zuddas, A., Zanni, R., & Usala, T. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.04.001 · Cited by 131
Zoëga, H., Furu, K., Halldórsson, M., Thomsen, P. H., Sourander, A., & Martikainen, J. E. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01607.x · Cited by 107
Antipsychotics for Children and Young Adults: A Comparative Effectiveness Review
Seida, J. C., Schouten, J. R., Boylan, K., Newton, A. S., Mousavi, S. S., Beaith, A., Vandermeer, B., Dryden, D. M., & Carrey, N. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2158 · Cited by 110
Status and perspectives of claims data analyses in Germany—A systematic review
Kreis, K., Neubauer, S., Klora, M., Lange, A., & Zeidler, J. (2016) · Health Policy · doi:10.1016/j.healthpol.2016.01.007 · Cited by 113
Bais, B., Molenaar, N. M., Bijma, H. H., Hoogendijk, W. J. G., Mulder, C. L., Luik, A. I., den Berg, M. P. L., & Kamperman, A. M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.014 · Cited by 107
Antipsychotic Prescription in Children and Adolescents
Bachmann, C., Lempp, T., Glaeske, G., & Hoffmann, F. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0025 · Cited by 104
Self-citationSidorchuk, A., Isomura, K., Molero, Y., Hellner, C., Lichtenstein, P., Chang, Z., Franck, J., de la Cruz, L. F., & Mataix‐Cols, D. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002635 · Cited by 102
Hsia, Y., Wong, A. Y. S., Murphy, D., Simonoff, E. A., Buitelaar, J. K., & Wong, I. C. K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3263-x · Cited by 101
Not robots: children's perspectives on authenticity, moral agency and stimulant drug treatments
Singh, I. (2012) · Journal of Medical Ethics · doi:10.1136/medethics-2011-100224 · Cited by 90
Steinhausen, H. ‐., & Bisgaard, C. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12155 · Cited by 88
Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review
Marasine, N. R., Sankhi, S., Lamichhane, R., Marasini, N. R., & Dangi, N. B. (2021) · BioMed Research International · doi:10.1155/2021/6699028 · Cited by 84
Hsia, Y., & Maclennan, K. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9321-3 · Cited by 84
Hartz, I., Skurtveit, S. O., Steffenak, A. K. M., Karlstad, Ø., & Handal, M. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0716-x · Cited by 83
Acquaviva, É., Legleye, S., Auleley, G.-R., Deligne, J., Carel, D., & Falissard, B. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-72 · Cited by 79
Knopf, H., Hölling, H., Huss, M., & Schlack, R. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000477 · Cited by 67
A multi-national comparison of antipsychotic drug use in children and adolescents, 2005–2012
Kalverdijk, L. J., Bachmann, C., Aagaard, L., Burcu, M., Glaeske, G., Hoffmann, F., Petersen, I., Schuiling‐Veninga, C. C. M., Wijlaars, L. P. M. M., & ZITO, J. M. (2017) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-017-0192-1 · Cited by 78
Self-citationAskari, S., & Salpekar, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00080-9 · Cited by 74
The Role of Atypical Antipsychotics for Treatment of Tourette’s Syndrome: An Overview
Budman, C. L. (2014) · Drugs · doi:10.1007/s40265-014-0254-0 · Cited by 66
Pisano, S., Catone, G., Veltri, S., Lanzara, V., Pozzi, M., Clementi, E., Iuliano, R., Riccio, M. P., Radice, S., Molteni, M., et al. (2016) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-016-0259-2 · Cited by 67
Bachmann, C. J., Manthey, T., Kamp-Becker, I., Glaeske, G., & Hoffmann, F. (2013) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2013.05.028 · Cited by 63
Self-citationHypnotic drug use among 0–17 year olds during 2004–2011: A nationwide prescription database study
Hartz, I., Furu, K., Bratlid, T., Handal, M., & Skurtveit, S. (2012) · Scandinavian Journal of Public Health · doi:10.1177/1403494812464446 · Cited by 55
Embry, D. D. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.11.003 · Cited by 56
Prescription drug dispensing profiles for one million children: a population-based analysis
Zhang, T., Smith, M. A., Camp, P. G., Shajari, S., MacLeod, S. M., & Carleton, B. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1343-1 · Cited by 53
Mehler‐Wex, C., Kölch, M. G., Kirchheiner, J., Antony, G., Fegert, J. M., & Gerlach, M. (2009) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-3-14 · Cited by 51
Self-citationMcKinney, C., & Renk, K. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.11.005 · Cited by 50
Sleep and Substance Use and Abuse in Adolescents
Gromov, I., & Gromov, D. (2009) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2009.04.004 · Cited by 49
Psychotropic Medication Use in French Children and Adolescents
Kovess–Masféty, V., Choppin, S., Gao, F., Pivette, M., Husky, M. M., & Leray, E. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0058 · Cited by 48
Antipsychotic Use in Children and Adolescents: A 1-Year Follow-Up Study
Baeza, I., de la Serna, E., Calvo, R. M., Morer, Á., Merchán‐Naranjo, J., Tapia, C., Martínez‐Cantarero, C., Andrés, P., Alda, J. A., Sánchez, B., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000190 · Cited by 47
Kaguelidou, F., Holstiege, J., Schink, T., Bezemer, I. D., Poluzzi, E., Mazzaglia, G., Pedersen, L. H., Sturkenboom, M., & Trifirò, G. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796020000293 · Cited by 47
Kölch, M. G., Prestel, A., Singer, H., Keller, F., Fegert, J. M., Schlack, R., Hoelling, H., & Knopf, H. C. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0018 · Cited by 47
Self-citationPolypharmacy with antidepressants in children and adolescents
Díaz‐Caneja, C. M., Espliego, A., Parellada, M., Arango, C., & Moreno, C. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001265 · Cited by 46
Schlander, M., Trott, G. E., & Schwarz, O. (2009) · Der Nervenarzt · doi:10.1007/s00115-009-2888-9 · Cited by 46
Psychotropic medicine prescriptions in Italian youths: a multiregional study
Piovani, D., Clavenna, A., Cartabia, M., & Bonati, M. R. (2015) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-015-0726-0 · Cited by 46
Jureidini, J. N., Tonkin, A., & Jureidini, E. (2013) · Pediatric Drugs · doi:10.1007/s40272-013-0032-6 · Cited by 45
Pediatric psychopharmacology: Too much or too little?
Rapoport, J. L. (2013) · World Psychiatry · doi:10.1002/wps.20028 · Cited by 44
van den Ban, E., Souverein, P. C., Swaab, H., van Engeland, H., Egberts, T. C. G., & Heerdink, E. R. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0044-9 · Cited by 39
Andersen, S. L., & Navalta, C. P. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02376.x · Cited by 38
A Qualitative Study of Antipsychotic Medication Experiences of Youth.
Murphy, A. L., Gardner, D. M., Kisely, S. R., Cooke, C., Kutcher, S., & Hughes, J. R. (2015) · Europe PMC (PubMed Central) · Cited by 41
Wong, A. Y. S., Hsia, Y., Chan, E. W., Murphy, D. G. M., Simonoff, E., Buitelaar, J. K., & Wong, I. C. K. (2014) · Autism Research · doi:10.1002/aur.1391 · Cited by 31
Mackie, T. I., Schaefer, A. J., Karpman, H. E., Lee, S. M., Bellonci, C., & Larson, J. J. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2020.08.441 · Cited by 38
Large increase of the use of psycho‐stimulants among youth in the Netherlands between 1996 and 2006
Trip, A., Visser, S. T., Kalverdijk, L. J., & den Berg, L. T. W. D. J. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03373.x · Cited by 38
Self-citationPsychotropic Drug Use Among Preschool Children in the Medicaid Program From 36 States
Garfield, L. D., Brown, D. S., Allaire, B. T., Ross, R. E., Nicol, G. E., & Raghavan, R. (2015) · American Journal of Public Health · doi:10.2105/ajph.2014.302258 · Cited by 37
Steffenak, A. K. M., Wilde‐Larsson, B., Nordström, Skurtveit, S. O., & Hartz, I. (2012) · Clinical Epidemiology · doi:10.2147/clep.s31624 · Cited by 37
Murphy, A. L., Gardner, D. M., Cooke, C., Kisely, S. R., Hughes, J. R., & Kutcher, S. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-198 · Cited by 36
Review on the current use of antipsychotic drugs in children and adolescents
Almandil, N. B., & Wong, I. C. K. (2011) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2011-300054 · Cited by 34
Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study
Boland, F., Galvin, R., Reulbach, U., Motterlini, N., Kelly, D., Bennett, K., & Fahey, T. P. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0435-3 · Cited by 34
Trends in psychopharmacologic treatment of tic disorders in children and adolescents in Germany
Bachmann, C., Roessner, V., Glaeske, G., & Hoffmann, F. (2014) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-014-0563-6 · Cited by 33
Self-citationStein, B. D., Leckman‐Westin, E., Okeke, E. N., Scharf, D. M., Sorbero, M., Chen, Q., Chor, K. H. B., Finnerty, M. T., & Wisdom, J. P. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0008 · Cited by 33
Tolerability and safety profile of risperidone in a sample of children and adolescents
Margari, L., Matera, E., Craig, F., Petruzzelli, M. G., Palmieri, V. O., Pastore, A., & Margari, F. (2013) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328362497b · Cited by 31
Long-Term Trend in Pediatric Antidepressant Use, 1983–2007: A Population-Based Study
Meng, X., D’Arcy, C., & Tempier, R. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900204 · Cited by 30
Gentile, S. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822bb1ff · Cited by 28
Alavi, Z., & Calleja, N. G. (2012) · PubMed · Cited by 28
Mind the Gap: Gender Differences in Child Special Health Care Needs
Leiter, V., & Rieker, P. P. (2011) · Maternal and Child Health Journal · doi:10.1007/s10995-011-0834-5 · Cited by 28
Hartz, I., Skurtveit, S. O., Hjellvik, V., Furu, K., Nesvåg, R., & Handal, M. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12633 · Cited by 28
Trends in Psychotropic Use in Saskatchewan from 1983 to 2007
Meng, X., D’Arcy, C., & Tempier, R. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800708 · Cited by 28
O’Sullivan, K., Reulbach, U., Boland, F., Motterlini, N., Kelly, D., Bennett, K., & Fahey, T. P. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007070 · Cited by 26
Psychopharmaka im Kindes- und Jugendalter
Kölch, M. G., Plener, P. L., & Fegert, J. M. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_92 · Cited by 26
Self-citationThe meteoric rise of mental illness in America and implications for other countries
Stolzer, J. M. (2016) · The European Journal of Counselling Psychology · doi:10.5964/ejcop.v4i2.77 · Cited by 25
Cothros, N., Martino, D., McMorris, C. A., Stewart, D., Tehrani, A., & Pringsheim, T. M. (2019) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.459 · Cited by 24
Franke, C., Fegert, J. M., Krüger, U., & Kölch, M. G. (2016) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000417 · Cited by 23
Self-citationTrends in the utilization of psychotropic medications in China from 2018 to 2021
Zhang, X., Hu, X., Zhao, Y., Lu, C. Y., Nie, X., & Shi, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.967826 · Cited by 22
The Ecology of ADHD in the Schools
Rogers, M., Boggia, J., Ogg, J. A., & Volpe, R. (2015) · Current Developmental Disorders Reports · doi:10.1007/s40474-015-0038-6 · Cited by 22
Antidepressant and antipsychotic use in an Italian pediatric population
Clavenna, A., Andretta, M., Pilati, P., Dusi, M., Gangemi, M., Gattoni, M. B., Lombardo, G., Zoccante, L., Mezzalira, L., & Bonati, M. R. (2011) · BMC Pediatrics · doi:10.1186/1471-2431-11-40 · Cited by 22
Pediatric Antipsychotic Use and Outcomes Monitoring
Santosh, P., Bell, L., Fiori, F., & Singh, J. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0247 · Cited by 22
Gyllenberg, D., & Sourander, A. (2012) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.644809 · Cited by 21
Pressman, R. M., & Imber, S. C. (2011) · American Journal of Family Therapy · doi:10.1080/01926187.2011.601218 · Cited by 21
Acquaviva, É., Peyre, H., & Falissard, B. (2011) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2011.10.009 · Cited by 20
Burden of psychiatric disorders in the pediatric population
Clavenna, A., Cartabia, M., Sequi, M., Costantino, M. A., Bortolotti, A., Fortino, I., Merlino, L. G., & Bonati, M. R. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.008 · Cited by 20
Internalizing and Externalizing Behaviors as Predictors of Sexual Onset in Early Adolescence
Boislard, M.-A., Dussault, F., Brendgen, M. R., & Vitaro, F. (2013) · The Journal of Early Adolescence · doi:10.1177/0272431612472982 · Cited by 21
Foulon, V., Svala, A., Koskinen, H., Chen, T. F., Saastamoinen, L., & Bell, J. S. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0040 · Cited by 19
Relation of Prenatal Smoking Exposure and Use of Psychotropic Medication up to Young Adulthood
Ekblad, M. O., Gissler, M., Lehtonen, L., & Korkeila, J. J. A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr150 · Cited by 19
Murphy, A. L., Gardner, D. M., Kisely, S. R., Cooke, C., Kutcher, S., & Hughes, J. R. (2015) · Clinical Child Psychology and Psychiatry · doi:10.1177/1359104515617518 · Cited by 19
Tsai, C., Yang, H., Islam, M. M., Hsieh, W.-S., Juan, S.-H., Chen, J.-C., Khan, H. A. A., & Jian, W. (2017) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzx123 · Cited by 19
Psychotropic Marketing Practices and Problems: Implications for DSM-5
Raven, M. K., & Parry, P. I. (2012) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e318257c6c7 · Cited by 19
International variation in the usage of medicines: A review of the literature
Nolte, E., Newbould, J., & Conklin, A. (2010) · RAND Corporation eBooks · doi:10.7249/tr830 · Cited by 19
Pragmatic measures in paediatric psychopharmacology — Are we getting it right?
Coghill, D. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.11.007 · Cited by 18
Ménard, M.-L., Thümmler, S., Giannitelli, M., Olliac, B., Bonnot, O., Cohen, D., & Askenazy-Gittard, F. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-011020 · Cited by 18
Schlander, M., Trott, G.-E., & Schwarz, O. (2009) · Der Nervenarzt · doi:10.1007/s00115-009-2889-8 · Cited by 18
Experience of psychotropic drug use among young people with mental health problems
Steffenak, A. K. M., Wilde‐Larsson, B., Hartz, I., & Nordström, G. M. (2015) · Nordic journal of nursing research · doi:10.1177/0107408315592805 · Cited by 17
Influence of socioeconomic status on antipsychotic prescriptions among youth in France
Bonnot, O., Dufresne, M., Herrera, P., Michaud, E., Pivette, J., Chaslerie, A., Sauvaget, A., & Victorri‐Vigneau, C. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1232-3 · Cited by 17
Variability in market uptake of psychotropic medications in Europe reflects cultural diversity
Hoebert, J. M., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., & van Dijk, L. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2649-6 · Cited by 17
Yang, B. K., Burcu, M., Safer, D. J., Trinkoff, A. M., & ZITO, J. M. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0112 · Cited by 17
Self-citationPietro, N. C. D., & Illes, J. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.131604 · Cited by 16
Ilies, D., Huet, A.-S., Lacourse, É., Roy, G., Stip, É., & Amor, L. B. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717718166 · Cited by 16
Metadata
- Authors
- Zito, J. M., Safer, D. J., Berg, L. T. D. J.-V. D., Janhsen, K., Fegert, J. M., Gardner, J. F., Glaeske, G., & Valluri, S. C.
- Affiliations
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- University of Groningen (NL)
- University of Bremen (DE)
- Corresponding author
- Zito, Julie M
- Venue
- Child and Adolescent Psychiatry and Mental Health
- Published
- 2008-09-25
- Volume
- 2
- Issue
- 1
- Pages
- 26-26
- ISSN
- 1753-2000 (ISSN-L)
- PMC
- PMC2569908
- OpenAlex
- W1996815465
- Cited by
- 201
- References
- 46
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 13 · 2022: 9 · 2021: 7 · 2020: 7 · 2019: 2 · 2018: 7 · 2017: 13 · 2016: 10 · 2015: 17 · 2014: 17 · 2013: 25 · 2012: 21
- FWCI
- 20.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Child and Adolescent Psychiatry and Mental Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- psychotropic drugs, youth, cross-national comparison, antidepressants, stimulants, antipsychotic drugs, atypical antipsychotics, anxiolytics, concomitant drug use, drug use prevalence, health policy, Netherlands, Germany, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.